Dr. Walter Jay Peet, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2145 Fairview Pl, Billings, MT 59102 Phone: 406-245-2037 |
Emilia A Ploplys, Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 13th Ave S, Suite 103, Great Falls, MT 59405 Phone: 406-731-8888 Fax: 406-731-8876 |
Dr. Michelle A Spring, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 60 Four Mile Dr Ste 11, Kalispell, MT 59901 Phone: 406-609-0210 Fax: 406-609-0211 |
John Wayne Harlan, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 900 N Orange St, Suite 106, Missoula, MT 59802 Phone: 406-542-7300 Fax: 406-542-0003 |
Dr. Stephanie Suprenant, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St Fl 5, Missoula, MT 59802 Phone: 406-370-1600 Fax: 406-329-5864 |
Dr. Robert W Alexander, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 715 Main St, Suite B, Stevensville, MT 59870 Phone: 406-777-4477 Fax: 866-766-5458 |
Sarah E Nargi, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5850 Hwy 93 S, Whitefish, MT 59937 Phone: 406-862-6808 |
News Archive
A physical activity and diet program implemented by health educators in physician offices appears to be associated with modest reductions in waist circumference among obese patients, according to a report published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals.
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
The National Football League pledged to support research to study the long-term repercussions of head traumas experienced by athletes and others, including members of the military.
CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that its orally-active, Aurora A/angiogenic kinase inhibitor, ENMD-2076, has received Orphan Drug designation from the U.S. Food and Drug Administration for the treatment of hepatocellular carcinoma (HCC).
› Verified 6 days ago